Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Inogen ( (INGN) ) is now available.
On January 25, 2025, Inogen announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. to expand their product portfolio and innovation pipeline, and to enter the Chinese market. This partnership involves distribution agreements and a $27.2 million equity investment from Yuwell, enhancing Inogen’s market positioning and financial stability.
More about Inogen
Inogen, Inc. is a global medical technology company specializing in innovative respiratory products for homecare settings. The company develops, manufactures, and markets respiratory therapy devices to aid patients with chronic respiratory conditions, collaborating with patients, prescribers, and distributors to enhance accessibility.
YTD Price Performance: 24.48%
Average Trading Volume: 200,363
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $272.5M
For detailed information about INGN stock, go to TipRanks’ Stock Analysis page.
